Research Summary
Fidaxomicin is an antibiotic medication used to treat infections caused by Clostridium difficile (C. difficile), a bacterium that can lead to severe and recurrent cases of diarrhea and colitis, often occurring in healthcare settings. Fidaxomicin belongs to a class of antibiotics known as macrocyclic antibiotics and works by inhibiting the growth of C. difficile by specifically targeting its RNA polymerase enzyme. This antibiotic is notable for its minimal systemic absorption, which allows it to act primarily within the gut, minimizing disruption to the natural balance of the gut microbiota. Fidaxomicin is considered a valuable treatment option, particularly in cases of recurrent C. difficile infections, as it has demonstrated efficacy and a lower risk of recurrence compared to some other antibiotics commonly used to treat this infection.
According to DIResearch's in-depth investigation and research, the global Fidaxomicin market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Fidaxomicin include Astellas, Merck, Optimer Pharmaceuticals, Rochem, Tecoland, BrightGene Bio-Medical Technology, Olon, Livzon Group etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Fidaxomicin. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Fidaxomicin market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Fidaxomicin market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Fidaxomicin industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Fidaxomicin Include:
Astellas
Merck
Optimer Pharmaceuticals
Rochem
Tecoland
BrightGene Bio-Medical Technology
Olon
Livzon Group
Fidaxomicin Product Segment Include:
Purity:90%
Purity:95%
Others
Fidaxomicin Product Application Include:
Hospital
Retail Pharmacies
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Fidaxomicin Industry PESTEL Analysis
Chapter 3: Global Fidaxomicin Industry Porter's Five Forces Analysis
Chapter 4: Global Fidaxomicin Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Fidaxomicin Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Fidaxomicin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Fidaxomicin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Fidaxomicin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Fidaxomicin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Fidaxomicin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Fidaxomicin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Fidaxomicin Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Fidaxomicin Market Overview 1.1 Product Definition and Statistical Scope 1.2 Fidaxomicin Product by Type 1.2.1 Global Fidaxomicin Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Purity:90% 1.2.3 Purity:95% 1.2.4 Others 1.3 Fidaxomicin Product by Application 1.3.1 Global Fidaxomicin Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Hospital 1.3.3 Retail Pharmacies 1.4 Global Fidaxomicin Market Revenue and Sales Analysis 1.4.1 Global Fidaxomicin Market Size Analysis (2019-2030) 1.4.2 Global Fidaxomicin Market Sales Analysis (2019-2030) 1.4.3 Global Fidaxomicin Market Sales Price Trend Analysis (2019-2030) 1.5 Fidaxomicin Market Development Status and Trends 1.5.1 Fidaxomicin Industry Development Status Analysis 1.5.2 Fidaxomicin Industry Development Trends Analysis 2 Fidaxomicin Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Fidaxomicin Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Fidaxomicin Market Analysis by Regions 4.1 Fidaxomicin Overall Market: 2023 VS 2024 VS 2030 4.2 Global Fidaxomicin Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Fidaxomicin Revenue and Market Share by Region (2019-2024) 4.2.2 Global Fidaxomicin Revenue Forecast by Region (2025-2030) 4.3 Global Fidaxomicin Sales and Forecast Analysis (2019-2030) 4.3.1 Global Fidaxomicin Sales and Market Share by Region (2019-2024) 4.3.2 Global Fidaxomicin Sales Forecast by Region (2025-2030) 4.4 Global Fidaxomicin Sales Price Trend Analysis (2019-2030) 5 Global Fidaxomicin Market Size by Type and Application 5.1 Global Fidaxomicin Market Size by Type 5.1.1 Global Fidaxomicin Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Fidaxomicin Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Fidaxomicin Market Size by Application 5.2.1 Global Fidaxomicin Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Fidaxomicin Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Fidaxomicin Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Fidaxomicin Market Size by Type 6.3.1 North America Fidaxomicin Sales by Type (2019-2030) 6.3.2 North America Fidaxomicin Revenue by Type (2019-2030) 6.4 North America Fidaxomicin Market Size by Application 6.4.1 North America Fidaxomicin Sales by Application (2019-2030) 6.4.2 North America Fidaxomicin Revenue by Application (2019-2030) 6.5 North America Fidaxomicin Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Fidaxomicin Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Fidaxomicin Market Size by Type 7.3.1 Europe Fidaxomicin Sales by Type (2019-2030) 7.3.2 Europe Fidaxomicin Revenue by Type (2019-2030) 7.4 Europe Fidaxomicin Market Size by Application 7.4.1 Europe Fidaxomicin Sales by Application (2019-2030) 7.4.2 ? Europe Fidaxomicin Revenue by Application (2019-2030) 7.5 Europe Fidaxomicin Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Fidaxomicin Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Fidaxomicin Market Size by Type 8.3.1 China Fidaxomicin Sales by Type (2019-2030) 8.3.2 China Fidaxomicin Revenue by Type (2019-2030) 8.4 China Fidaxomicin Market Size by Application 8.4.1 China Fidaxomicin Sales by Application (2019-2030) 8.4.2 China Fidaxomicin Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Fidaxomicin Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Fidaxomicin Market Size by Type 9.3.1 APAC (excl. China) Fidaxomicin Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Fidaxomicin Revenue by Type (2019-2030) 9.4 APAC (excl. China) Fidaxomicin Market Size by Application 9.4.1 APAC (excl. China) Fidaxomicin Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Fidaxomicin Revenue by Application (2019-2030) 9.5 APAC (excl. China) Fidaxomicin Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Fidaxomicin Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Fidaxomicin Market Size by Type 10.3.1 Latin America Fidaxomicin Sales by Type (2019-2030) 10.3.2 Latin America Fidaxomicin Revenue by Type (2019-2030) 10.4 Latin America Fidaxomicin Market Size by Application 10.4.1 Latin America Fidaxomicin Sales by Application (2019-2030) 10.4.2 Latin America Fidaxomicin Revenue by Application (2019-2030) 10.5 Latin America Fidaxomicin Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Fidaxomicin Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Fidaxomicin Market Size by Type 11.3.1 Middle East & Africa Fidaxomicin Sales by Type (2019-2030) 11.3.2 Middle East & Africa Fidaxomicin Revenue by Type (2019-2030) 11.4 Middle East & Africa Fidaxomicin Market Size by Application 11.4.1 Middle East & Africa Fidaxomicin Sales by Application (2019-2030) 11.4.2 Middle East & Africa Fidaxomicin Revenue by Application (2019-2030) 11.5 Middle East & Africa Fidaxomicin Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Fidaxomicin Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Fidaxomicin Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Fidaxomicin Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Fidaxomicin Average Sales Price by Manufacturers (2020-2024) 12.2 Fidaxomicin Competitive Landscape Analysis and Market Dynamic 12.2.1 Fidaxomicin Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Astellas 13.1.1 Astellas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Astellas Fidaxomicin Product Portfolio 13.1.3 Astellas Fidaxomicin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Merck 13.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Merck Fidaxomicin Product Portfolio 13.2.3 Merck Fidaxomicin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Optimer Pharmaceuticals 13.3.1 Optimer Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Optimer Pharmaceuticals Fidaxomicin Product Portfolio 13.3.3 Optimer Pharmaceuticals Fidaxomicin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Rochem 13.4.1 Rochem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Rochem Fidaxomicin Product Portfolio 13.4.3 Rochem Fidaxomicin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Tecoland 13.5.1 Tecoland Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Tecoland Fidaxomicin Product Portfolio 13.5.3 Tecoland Fidaxomicin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 BrightGene Bio-Medical Technology 13.6.1 BrightGene Bio-Medical Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 BrightGene Bio-Medical Technology Fidaxomicin Product Portfolio 13.6.3 BrightGene Bio-Medical Technology Fidaxomicin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Olon 13.7.1 Olon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Olon Fidaxomicin Product Portfolio 13.7.3 Olon Fidaxomicin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Livzon Group 13.8.1 Livzon Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Livzon Group Fidaxomicin Product Portfolio 13.8.3 Livzon Group Fidaxomicin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Fidaxomicin Industry Chain Analysis 14.2 Fidaxomicin Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Fidaxomicin Typical Downstream Customers 14.4 Fidaxomicin Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support